Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1980 4
1983 2
1984 1
1985 1
1986 2
1987 2
1989 3
1990 4
1991 7
1992 4
1993 2
1994 6
1995 5
1996 2
1997 8
1998 4
1999 3
2000 10
2001 8
2002 14
2003 12
2004 8
2005 15
2006 6
2007 13
2008 23
2009 21
2010 22
2011 15
2012 17
2013 18
2014 16
2015 22
2016 28
2017 32
2018 22
2019 16
2020 18
2021 24
2022 22
2023 22
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

444 results

Results by year

Filters applied: . Clear all
Page 1
Cardiac amyloidosis.
Martinez-Naharro A, Hawkins PN, Fontana M. Martinez-Naharro A, et al. Clin Med (Lond). 2018 Apr 1;18(Suppl 2):s30-s35. doi: 10.7861/clinmedicine.18-2-s30. Clin Med (Lond). 2018. PMID: 29700090 Free PMC article. Review.
The need for a high index of suspicion and the critical importance of precise biochemical typing of the amyloid deposits is paramount in light of recent therapeutic advances that can significantly improve prognosis. Most cases of cardiac amyloidosis are of either transthyr …
The need for a high index of suspicion and the critical importance of precise biochemical typing of the amyloid deposits is paramount in lig …
Restrictive Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy.
Muchtar E, Blauwet LA, Gertz MA. Muchtar E, et al. Circ Res. 2017 Sep 15;121(7):819-837. doi: 10.1161/CIRCRESAHA.117.310982. Circ Res. 2017. PMID: 28912185 Review.
The restrictive cardiomyopathies are a heterogenous group of myocardial diseases that vary according to pathogenesis, clinical presentation, diagnostic evaluation and criteria, treatment, and prognosis. In this review, an overview of RCMs will be presented followed by a de …
The restrictive cardiomyopathies are a heterogenous group of myocardial diseases that vary according to pathogenesis, clinical presentation, …
Differentiation of Constriction and Restriction: Complex Cardiovascular Hemodynamics.
Geske JB, Anavekar NS, Nishimura RA, Oh JK, Gersh BJ. Geske JB, et al. J Am Coll Cardiol. 2016 Nov 29;68(21):2329-2347. doi: 10.1016/j.jacc.2016.08.050. J Am Coll Cardiol. 2016. PMID: 27884252 Free article. Review.
Because CP is a potentially curable cause of heart failure and therapeutic options for RCM are limited, distinction of these 2 conditions is critical. Although different in regard to etiology, prognosis, and treatment, CP and RCM share a common clinical presentation of pre …
Because CP is a potentially curable cause of heart failure and therapeutic options for RCM are limited, distinction of these 2 conditions is …
Cardiac Amyloidosis: Overlooked, Underappreciated, and Treatable.
Rubin J, Maurer MS. Rubin J, et al. Annu Rev Med. 2020 Jan 27;71:203-219. doi: 10.1146/annurev-med-052918-020140. Annu Rev Med. 2020. PMID: 31986086 Review.
This review summarizes the epidemiology, pathophysiology, diagnosis, prognosis, and management of CA with an emphasis on the significance of recent developments and suggested future directions....
This review summarizes the epidemiology, pathophysiology, diagnosis, prognosis, and management of CA with an emphasis on the signific …
Cardiac Amyloidosis Treatment.
Stern LK, Patel J. Stern LK, et al. Methodist Debakey Cardiovasc J. 2022 Mar 14;18(2):59-72. doi: 10.14797/mdcvj.1050. eCollection 2022. Methodist Debakey Cardiovasc J. 2022. PMID: 35414852 Free PMC article. Review.
Cardiac amyloidosis (CA) is a restrictive cardiomyopathy with a traditionally poor prognosis. Until recently, CA treatment options were limited and consisted predominantly of managing symptoms and disease-related complications. ...
Cardiac amyloidosis (CA) is a restrictive cardiomyopathy with a traditionally poor prognosis. Until recently, CA treatment options we …
Cardiac amyloidosis: An update on pathophysiology, diagnosis, and treatment.
Siddiqi OK, Ruberg FL. Siddiqi OK, et al. Trends Cardiovasc Med. 2018 Jan;28(1):10-21. doi: 10.1016/j.tcm.2017.07.004. Epub 2017 Jul 13. Trends Cardiovasc Med. 2018. PMID: 28739313 Free PMC article. Review.
Cardiac involvement is associated with symptoms of heart failure, and dictates the clinical course of the disease. Cardiac amyloidosis can be diagnosed noninvasively by echocardiography, cardiac MRI, or nuclear scintigraphy. ...
Cardiac involvement is associated with symptoms of heart failure, and dictates the clinical course of the disease. Cardiac amyloidosi …
Restrictive cardiomyopathy.
Zangwill S, Hamilton R. Zangwill S, et al. Pacing Clin Electrophysiol. 2009 Jul;32 Suppl 2:S41-3. doi: 10.1111/j.1540-8159.2009.02383.x. Pacing Clin Electrophysiol. 2009. PMID: 19602161 Review.
BACKGROUND: Restrictive cardiomyopathy is characterized by ventricular diastolic dysfunction with a clinical course in childhood that is often progressive despite medical therapy. ...
BACKGROUND: Restrictive cardiomyopathy is characterized by ventricular diastolic dysfunction with a clinical course in childhood that …
Heart failure in cardiomyopathies: a position paper from the Heart Failure Association of the European Society of Cardiology.
Seferović PM, Polovina M, Bauersachs J, Arad M, Ben Gal T, Lund LH, Felix SB, Arbustini E, Caforio ALP, Farmakis D, Filippatos GS, Gialafos E, Kanjuh V, Krljanac G, Limongelli G, Linhart A, Lyon AR, Maksimović R, Miličić D, Milinković I, Noutsias M, Oto A, Oto Ö, Pavlović SU, Piepoli MF, Ristić AD, Rosano GMC, Seggewiss H, Ašanin M, Seferović JP, Ruschitzka F, Čelutkiene J, Jaarsma T, Mueller C, Moura B, Hill L, Volterrani M, Lopatin Y, Metra M, Backs J, Mullens W, Chioncel O, de Boer RA, Anker S, Rapezzi C, Coats AJS, Tschöpe C. Seferović PM, et al. Eur J Heart Fail. 2019 May;21(5):553-576. doi: 10.1002/ejhf.1461. Epub 2019 Apr 16. Eur J Heart Fail. 2019. PMID: 30989768 Free article.
A timely treatment is important, since development of advanced HF, although rare in HCM, portends a poor prognosis. In RCM, HFpEF is common, while HFrEF occurs later and more frequently in amyloidosis or iron overload/haemochromatosis. ...
A timely treatment is important, since development of advanced HF, although rare in HCM, portends a poor prognosis. In RCM, HFpEF is …
Amyloid cardiomyopathy.
Karafiatova L, Pika T. Karafiatova L, et al. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2017 Jun;161(2):117-127. doi: 10.5507/bp.2017.001. Epub 2017 Feb 1. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2017. PMID: 28145535 Free article.
Despite signal development in diagnostics and therapy, the prognosis for patients with advanced cardiac involvement remains poor. This article is an overview of amyloidosis, providing information about the characteristics of cardiac amyloidosis, and present a structured ap …
Despite signal development in diagnostics and therapy, the prognosis for patients with advanced cardiac involvement remains poor. Thi …
Accurate Classification of Non-ischemic Cardiomyopathy.
Wang Y, Jia H, Song J. Wang Y, et al. Curr Cardiol Rep. 2023 Oct;25(10):1299-1317. doi: 10.1007/s11886-023-01944-0. Epub 2023 Sep 15. Curr Cardiol Rep. 2023. PMID: 37721634 Free PMC article. Review.
PURPOSE OF REVIEW: This article aims to review the accurate classification of non-ischemic cardiomyopathy, including the methods, basis, subtype characteristics, and prognosis, especially the similarities and differences between different classifications. ...This article d …
PURPOSE OF REVIEW: This article aims to review the accurate classification of non-ischemic cardiomyopathy, including the methods, basis, sub …
444 results